(2025)
A droplet microfluidic strategy for cultivation, investigation, and high-throughput isolation of mouse gut microbiome bacteria.
Appl Environ Microbiol 91(8),
e0069525.
Publikationen
(2025)
Synergistic interactions between Candida albicans and Enterococcus faecalis promote toxin-dependent host cell damage.
Proc Natl Acad Sci U S A 122(46),
e2505310122.
(2025)
Identification of a fungal antibacterial endopeptidase that cleaves peptidoglycan.
EMBO Rep 26(1),
3889-3916.
(2025)
The murine lung microbiome is disbalanced by the human-pathogenic fungus Aspergillus fumigatus resulting in enrichment of anaerobic bacteria.
Cell Rep 44(3),
115442.
(2024)
A highly conserved tRNA modification contributes to C. albicans filamentation and virulence.
Microbiol Spectr 12(5),
e0425522.
(2024)
Infection models for human pathogenic fungi.
In: Brakhage AA, Kniemeyer O, Zipfel PF (eds.) The Mycota - Human and Animal Relationships 3. 6, pp. 193-206. Springer, Cham.
ISBN: 978-3-031-64853. (Review)
(2023)
The role of host and fungal factors in the commensal-to-pathogen transition of Candida albicans.
Curr Clin Micro Rpt 10(2),
55-65.
(Review)
(2023)
Mouse models of Mucormycosis.
Methods Mol Biol 2667,
181-196.
(Review)
(2023)
Soluble enolase 1 of Candida albicans and Aspergillus fumigatus stimulates human and mouse B cells and monocytes.
J Immunol 211(5),
804-815.
(2023)
Escherichia coli nissle 1917 antagonizes Candida albicans growth and protects intestinal cells from C. albicans-mediated damage.
Microorganisms 11(8),
1929.